FDA Inspection 903598 — Genesis Fertility & Reproductive Medicine

Genesis Fertility & Reproductive Medicine — FEI 3003972326

The FDA completed an inspection of Genesis Fertility & Reproductive Medicine on November 20, 2014 in Brooklyn, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Brooklyn, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible